Tech Company Financing Transactions
Evalve Funding Round
Evalve, based in Menlo Park, raised $35 million from Guidant, Cutlass Capital and Delphi Ventures.
Transaction Overview
Company Name
Announced On
5/24/2004
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series C
Investors
Proceeds Purpose
We will use these funds to continue our efforts to provide new and less invasive treatment options for patients suffering from cardiac valve disease.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
4045 Campbell Ave
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Evalve, Inc. is a leader in innovative devices for the endovascular repair of cardiac valves. The company's initial products are intended to reduce the risks, trauma and costs associated with current open, arrested heart surgical options.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ferolyn Powell
Chief Financial Officer
Doug Hughes
Vice President
Jonathan Feuchtwang
Vice President
Jan Komtebedde
VP - Operations
Bunty Banerjee
VP - R & D
Troy Thornton
VP - Regulatory Affairs
Liz McDermott
VP - Sales
Sean Cleary
VP - Sales
Chris Richardson
Browse more venture capital transactions:
Prev: 5/24/2004: Millennial Net venture capital transaction
Next: 5/24/2004: Autotask venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs